The recent discovery of some agonists at opioid receptor lacking the protonatable amino group [1], leads to the re-discussion of the importance of ionic interactions in stabilizing the ligand-receptor complex and in activating signal transduction. Recently, we have synthesized cyclic analogues of endomorphin-1 (EM-1), containing different Xaa5 bridges between Tyr1 and Phe4. These lipophilic, cyclic EM-1 analogues displayed good affinities for MORs, allowing to hypothesize that they could interact with the receptor by a peculiar, alternative fashion, which has been investigated by Molecular Docking. The docking results gave a detailed description of ligand binding interactions and their electronic properties. The comparison with the agonist JOM-6 binding mode [50,51] indicated that the cyclic EM-1 analogues have an alternative interaction mechanism, still maintaining the ability to activate the receptor.
G. Bombieri, R. Artali, L. Gentilucci, R. De Marco, S. Spampinato, A. Bedini (2008). Investigation on MOR receptor activation by atypical mechanisms. s.l : s.n.
Investigation on MOR receptor activation by atypical mechanisms
GENTILUCCI, LUCA;DE MARCO, ROSSELLA;SPAMPINATO, SANTI MARIO;BEDINI, ANDREA
2008
Abstract
The recent discovery of some agonists at opioid receptor lacking the protonatable amino group [1], leads to the re-discussion of the importance of ionic interactions in stabilizing the ligand-receptor complex and in activating signal transduction. Recently, we have synthesized cyclic analogues of endomorphin-1 (EM-1), containing different Xaa5 bridges between Tyr1 and Phe4. These lipophilic, cyclic EM-1 analogues displayed good affinities for MORs, allowing to hypothesize that they could interact with the receptor by a peculiar, alternative fashion, which has been investigated by Molecular Docking. The docking results gave a detailed description of ligand binding interactions and their electronic properties. The comparison with the agonist JOM-6 binding mode [50,51] indicated that the cyclic EM-1 analogues have an alternative interaction mechanism, still maintaining the ability to activate the receptor.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.